Average Co-Inventor Count = 6.40
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astrazeneca Ab (9 from 1,500 patents)
2. Mitsubishi Tanabe Pharma Corporation (1 from 257 patents)
9 patents:
1. 12024523 - Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
2. 11691978 - Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
3. 11667602 - Compounds and their use
4. 11001589 - Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
5. 10508119 - Pyrazole derivatives useful as 5-lipdxygenase activating protein (FLAP) inhibitors
6. 10183947 - Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
7. 8361998 - Compounds and their use as IKACh blockers
8. 7678796 - MGluR5 modulators I
9. 7419979 - Derivatives of 6-{4-[4-(1H-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one